#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Spinal cord injury Plasma cell myeloma recurrent Immune-mediated myositis Short stature Subarachnoid haemorrhage Parkinson's disease Pyoderma gangrenosum Inborn error of metabolism Chondrosarcoma metastatic Paget's disease of the vulva Growth hormone deficiency Hereditary spastic paraplegia Arginase deficiency Retinoblastoma Selective polysaccharide antibody deficiency More trials…

    Learn about Rare Diseases

    Cytokine release syndrome Leiomyosarcoma – Treatment Wiskott-Aldrich syndrome – Life with Disease Chordoma – Diagnostics Atypical haemolytic uraemic syndrome – Trials in Disease Chondrosarcoma – Diagnostics Mantle cell lymphoma – Treatment Usher’s syndrome – Basic Information Immunodeficiency congenital Glomerulonephritis membranoproliferative – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    CC-97540 Bisoprolol Fumarate Blu-263 Phosphate Alglucosidase Alfa Omeprazole Elinzanetant Cinnarizine Bjt-778 PF-07868489 Soya Oil, Purified ALE1 Sufentanil Citrate Nifedipine Alrefimotide Syn2 Cevostamab Calcium Chloride Hexahydrate CIRTUVIVINT 177LU-PSMA-I&T Dazukibart More therapies…

    Learn about Your Condition

    Suicidal ideation Colorectal adenocarcinoma Retinopathy of prematurity Malignant melanoma stage II Ovarian epithelial cancer Injection site pain Cholangiocarcinoma Erosive oesophagitis Myasthenia gravis Renal failure Colorectal cancer stage IV Gastrooesophageal cancer Vertigo Gallbladder cancer Respiratory failure More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Asklepios Kliniken Hamburg GmbH

Asklepios Kliniken Hamburg GmbH

Eissendorfer Pferdeweg 52, Heimfeld, Hamburg, 21075, Germany

Want to learn more about this study or check if you can participate? Contact us.

  • Study to Determine the Best Dose of Zongertinib with Trastuzumab Deruxtecan or Trastuzumab Emtansine for Patients with Advanced HER2+ Metastatic Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Oesophageal carcinoma
    • Adenocarcinoma gastric
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Zanidatamab
    • Calcium Folinate
    • Capecitabine
    Belgium France Germany Italy Spain

  • Study Comparing Mezigdomide, Bortezomib, and Dexamethasone with Pomalidomide, Bortezomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma refractory
    Investigated Drugs:
    • Bortezomib
    • Dexamethasone
    • Mezigdomide
    Austria Belgium Czechia Finland France Germany +7

  • Study on Using ctDNA to Guide Treatment in Patients with Metastatic Colorectal Cancer Using Oxaliplatin, Capecitabine, Calcium Folinate, Irinotecan, and Fluorouracil

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Gimeracil
    • Oteracil
    • Tegafur
    Denmark Germany Norway

  • Study on Venetoclax and Drug Combination for Adults with Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome with Excess Blasts-2

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cytarabine
    • Daunorubicin
    • Venetoclax
    Austria Belgium Estonia Finland Germany Lithuania +2

  • Study of Amivantamab and Chemotherapy Drug Combination for Patients with Advanced or Metastatic Colorectal Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • ANHYDROUS CALCIUM FOLINATE
    • Irinotecan Hydrochloride Trihydrate
    • Amivantamab
    Belgium Germany Italy Spain

  • Study on Treatment Options for Patients with Oligometastatic Pancreatic Cancer: Comparing Oxaliplatin, Fluorouracil, Folinic Acid, and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    • Fluorouracil
    • Folinic Acid
    Finland Germany The Netherlands Sweden

  • Study Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Iberdomide
    • Apixaban
    • Rivaroxaban
    Austria Belgium Czechia Denmark Finland France +10

  • Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Heart failure with preserved ejection fraction
    Investigated Drugs:
    • Azd5004
    • Dapagliflozin
    Austria Bulgaria Czechia France Germany Greece +8

  • Study of divarasib and pembrolizumab compared to standard chemotherapy in previously untreated KRAS G12C-mutated advanced non-small cell lung cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • K-ras gene mutation
    • Non-small cell lung cancer
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Divarasib
    • Budesonide
    • Carboplatin
    Belgium Denmark France Germany Greece Hungary +6

  • A study of pumitamig and a drug combination versus bevacizumab and a drug combination for patients with untreated, unresectable, or metastatic colorectal cancer

    Recruiting

    4 1 1 1
    Investigated Drugs:
    • Irinotecan Hydrochloride Trihydrate
    • Bevacizumab
    • Calcium Folinate
    Austria Belgium Czechia France Germany Italy +5
Previous Page
1 … 4 5 6 7 8 … 13
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!